Nektar Therapeutics filed a Form 8-K on November 13, 2026, disclosing via Regulation FD that the company held $952.9 million in cash and investments in marketable securities as of September 30, 2026, and expects that balance to extend its cash runway into the third …
Silence Therapeutics plc filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the fiscal quarter ended September 30, 2026, and disclosing a significant increase in cash and cash equivalents alongside a pending acquisition by Merck KGaA, Darmstadt, Germany.
Nova Minerals Corp. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the three months ended September 30, 2026, disclosing a net loss of $12,046,928 and cash of $17,762,388 at quarter end.
Enovix Corporation filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 13, 2026, covering the fiscal quarter ended October 4, 2026.
Nova Minerals Corp filed a Form 8-K on November 13, 2026, furnishing a press release under Regulation FD that announced the securing of final antimony permits and reported quarterly operational progress.
Cartesian Growth Corporation IV, a Cayman Islands blank-check company listed on NASDAQ:CGCF, filed its Form 10-Q for the quarter ended September 30, 2026 on November 13, 2026, covering the period from inception on February 20, 2026 through that date.
GigCapital9 Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 13, 2026, covering the company's first operating quarters following its initial public offering.
HawkEye 360, Inc. filed its quarterly report on Form 10-Q with the SEC on November 13, 2026, covering the period ended September 30, 2026, disclosing condensed consolidated financial statements and management discussion for the third quarter of fiscal year 2026.
REalloys Inc. filed a Form 10-Q with the U.S. Securities and Exchange Commission on November 13, 2026, covering the quarterly period ended September 30, 2026, disclosing a net loss of $174,075 thousand for the nine months ended September 30, 2026, alongside significant changes in …
Buda Juice, Inc. filed a Form 10-Q with the SEC on November 13, 2026, reporting unaudited financial results for the quarterly period ended September 30, 2026, its first filing period following an initial public offering completed earlier in the year.